Mary Chapman, features writer —

The Sickle Cell Disease Association of America (SCDAA) is collaborating with several pharmaceutical companies in a new initiative aimed at increasing awareness of the blood disorder and promoting clinical trial participation. Along with the SCDAA, the Sickle Cell Disease Collaboration of Advocates for Research, Education, and Science — officially…

Suburban Propane Partners recently teamed up with the American Red Cross, its longtime national collaborator, to host a blood drive in Boston to boost sickle cell disease (SCD) awareness and encourage blood donations. The event was attended by Willie Gross, Boston’s former, and first, African American police commissioner. Some…

Louisiana State University’s (LSU) Reilly Center for Media & Public Affairs will kick off season six of its Racism: Dismantling the System series on Feb. 15 with a free Zoom presentation on healthcare and people of color. The 3:30 p.m. CST event, presented in partnership with the Sickle Cell Association…

Continuing its partnership with the Sickle Cell Disease Association of America (SCDAA), medical technology company Hemanext is working with the SCDAA’s Miami chapter to offer community-focused educational programs and local events. Hemanext focuses on improving the quality, safety, efficacy, and cost of blood transfusions, which are often…

To underscore the importance of understanding and getting tested for the sickle cell trait (SCT), the Cayenne Wellness Center has launched a campaign targeting California’s students, school athletes, parents, and educators. The five-year Sickle Cell Trait Awareness Campaign will offer resources that will help educate people about SCT and…

The sickle cell disease (SCD) treatment program at Loma Linda University Children’s Hospital in California has been recognized as a center of excellence, joining dozens of other centers in the U.S. affiliated with the National Alliance for Sickle Cell Centers (NASCC). The NASCC identifies “member” centers based on…

UC San Diego Health has won the 2022 California Association of Public Hospitals and Health Systems (CAPH) Quality Leaders Award in the health equity category for its  same-day outpatient infusion program, which seeks to mitigate healthcare disparities in sickle cell disease (SCD). Each year, the CAPH recognizes initiatives by…

A $100,000 grant from Global Blood Therapeutics (GBT) will help expand a novel nurse training program at the University of Tennessee Health Science Center (UTHSC) that aims to improve care for sickle cell disease (SCD) patients. The free training program — a “boot camp” for registered nurses —…

The Sickle Cell Disease Association of America (SCDAA) has granted its President’s Award to board-certified nurse practitioner Genice Nelson, PhD,  of UConn Health’s New England Sickle Cell Institute (NESCI) Nelson was honored for her hard work and “immeasurable” dedication to the sickle cell community, and specifically for her…

In a $5.4 billion deal, Pfizer fully acquired Global Blood Therapeutics (GBT), bolstering its decades-long standing in the field of rare blood disorders, particularly regarding sickle cell disease (SCD). With the newly completed acquisition — plans were announced in August — Pfizer gains GBT’s therapy portfolio and pipeline.